HPC_HPVM Technical Whitepaper #2(Japanese) AI-PV HiroPharma Validation Method (HPVM) — Regulatory-Ready Human-Based Validation Framework for AI-Enabled PV Systems - #2 | Updated: 22-Dec-2025 2026.08.30
Pressrelease:HiroPharmaConsulting® Launches AI-PV POC/FS Consulting Service Supporting AI Use in Intake & Triage and Literature Screening from a Human Oversight Perspective HiroPharmaConsulting® 2026.05.04
HPC_HPVM Technical Whitepaper #2(English) AI-PV HiroPharma Validation Method (HPVM) — Regulatory-Ready Human-Based Validation Framework for AI-Enabled PV Systems - #2 | Updated: 22-Dec-2025 2025.12.22
HPC_HPVM Whitepaper v2.0(English) AI-PV HiroPharma Validation Method (HPVM) — Regulatory-Ready Human-Based Validation Framework for AI-Enabled PV Systems — Version 2.0 | Updated: 05-Dec-2025 2025.12.04
FDA : Considerations for the Use of Artificial Intelligence to Support Regulatory Decision/Making for Drug and Biological Products (Draft) , Draft Guidance for Industry and Other Interested Parties/ Docket Number:FDA/2024/D/4689 2025.05.14
India 「インド規制当局:中央医薬品基準管理機構(CDSCO)」[Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products Version: 2.0] 2025.04.23
[Press Release 20250211] "Launch of GVP validation consulting service for evaluation of PV System introduction with AI function" 2025.02.12